Systemic Inflammatory Indices and Free Flap Outcomes in Oral Cavity Cancer Reconstruction: A Multicenter Cohort Study
Microsurgery · 2026-12 · 46 (8)
DOI: 10.1002/micr.70335 ↗Abstract
ABSTRACT Background Free flap reconstruction is central to oral cavity cancer (OCC) management; however, flap‐related complications remain clinically consequential. Current perioperative strategies are largely reactive, and reliable preoperative markers identifying patients at increased risk of flap‐related complications are lacking. This study aimed to evaluate the association between preoperative systemic inflammatory indices and free flap‐related complications in OCC reconstruction. Methods We performed a retrospective, multicenter cohort study using the Chang Gung Research Database, including patients undergoing ablative surgery with free flap reconstruction (2002–2022). Preoperative laboratory data obtained within 30 days before surgery were used to calculate the neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), and lymphocyte‐to‐monocyte ratio (LMR). The primary outcome was flap‐related complications, defined as surgical re‐exploration within 30 days. Multivariable logistic regression models were used to estimate adjusted odds ratios (aORs) with prespecified clinical covariates. Results Among 7444 patients, 10.9% required re‐exploration, including 3.5% with total flap loss and 7.3% with flap revision. Elevated NLR (≥ 4.0) was associated with higher complication risk (aOR = 1.36; 95% CI = 1.15–1.60; p = 0.001), whereas higher LMR (≥ 4.36) was protective (aOR = 0.68; 95% CI = 0.58–0.81; p < 0.001). These associations were consistent across both flap revision and total flap failure. Conclusions Preoperative NLR and LMR provide incremental risk stratification beyond established clinical factors and may serve as clinically accessible markers of free flap‐related risk in OCC reconstruction. These findings support a more refined, risk‐adapted approach to perioperative assessment, although prospective validation is required.
EUVIMED